These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16123483)

  • 1. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
    Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.
    Ozturk A; Kucukardali Y; Tangi F; Erikci A; Uzun G; Bashekim C; Sen H; Terekeci H; Narin Y; Ozyurt M; Ozkan S; Sayan O; Rodop O; Nalbant S; Sıldıroglu O; Yalnız FF; Senkal IV; Sabuncu H; Oktenli C
    J Diabetes Complications; 2012; 26(1):29-33. PubMed ID: 22240264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia.
    Mohammadzadeh L; Samedanifard SH; Keshavarzi A; Alimoghaddam K; Larijani B; Ghavamzadeh A; Ahmadi AS; Shojaeifard A; Ostadali MR; Sharifi AM; Amini MR; Mahmoudian A; Fakhraei H; Aalaa M; Mohajeri-Tehrani MR
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):48-53. PubMed ID: 23329572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
    Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
    Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Fadini GP; Avogaro A
    Diabetes Care; 2006 Feb; 29(2):478-9; author reply 479-80. PubMed ID: 16482702
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells.
    Li S; Zhou B; Han ZC
    Thromb Haemost; 2006 Feb; 95(2):301-11. PubMed ID: 16493493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
    Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
    Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.
    Zhou B; Bi YY; Han ZB; Ren H; Fang ZH; Yu XF; Poon MC; Han ZC
    J Thromb Haemost; 2006 May; 4(5):993-1002. PubMed ID: 16689750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and efficacy of intracoronary transplantation of G-CSF mobilized autologous peripheral blood stem cells in patients with acute myocardial infarction].
    Li ZQ; Zhang M; Jin YZ; Zhang WW; Liu Y; Yuan L; Cui LJ; Liu XZ; Yu X; Hu TS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):99-102. PubMed ID: 16626571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
    Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
    Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder].
    Yang XF; Wu YX; Wang HM; Xu YF; Lü X; Zhang YB; Wang F; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):95-8. PubMed ID: 15840218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia.
    Sun L; Wu L; Qiao Z; Yu J; Li L; Li S; Liu Q; Hu Y; Xu N; Huang P
    Cytotherapy; 2014 Aug; 16(8):1110-6. PubMed ID: 24834816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ischemic limbs by transplantation of G-CSF stimulated bone marrow cells in diabetic rabbits.
    Meng J; Yao X; Kang S; Kang S; Yang Y; Zhou C
    Clin Invest Med; 2010 Jun; 33(3):E174-80. PubMed ID: 20519096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.